Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - STOCK-BASED COMPENSATION
Stock-based Compensation TRVI - Trevi Therapeutics, Inc.
2.25 M
LAST VALUE
-6.00%
2 YEAR CAGR
35.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR